Department of Immunopathology, Gifu University Graduate School of Medicine, Gifu, Japan.
Int J Exp Pathol. 2014 Feb;95(1):24-8. doi: 10.1111/iep.12051. Epub 2013 Oct 31.
A recent global gene expression profiling study unexpectedly showed that activated oncogenic NRAS may recruit neural precursor cell expressed, developmentally downregulated 4L (Nedd4L; a human homologue of Nedd4-2) in cultured melanoma cells. However, whether Nedd4L was expressed in melanoma tissues or participated in melanoma carcinogenesis remains to be clarified. Here, we investigated the expression status of Nedd4L in human melanocytes, benign nevi and melanoma tissue specimens and subsequently attempted to determine the role of Nedd4L in melanoma cell growth. Immunohistochemical staining revealed that Nedd4L was not present in any non-tumorous melanocytes or in 18 benign nevi tissues, but it was detected in 34 of 79 cutaneous melanomas and 9 of 32 nodal metastatic melanomas. Downregulation of Nedd4L significantly reduced the growth of cultured G361 melanoma cells in vitro. Moreover, exogenous Nedd4L expression significantly promoted the growth of A2058 melanoma cells in vivo in a xenograft assay. The present findings indicate that Nedd4L expression may be increased to facilitate tumour growth in many melanomas.
最近的一项全球基因表达谱研究出人意料地表明,在培养的黑色素瘤细胞中,激活的致癌 NRAS 可能招募神经前体细胞表达的、发育下调的 4L(Nedd4L;Nedd4-2 的人类同源物)。然而,Nedd4L 是否在黑色素瘤组织中表达或参与黑色素瘤的发生仍然需要澄清。在这里,我们研究了 Nedd4L 在人类黑素细胞、良性痣和黑色素瘤组织标本中的表达状态,随后试图确定 Nedd4L 在黑色素瘤细胞生长中的作用。免疫组织化学染色显示,Nedd4L 不存在于任何非肿瘤性黑素细胞或 18 个良性痣组织中,但在 79 个皮肤黑色素瘤中的 34 个和 32 个淋巴结转移性黑色素瘤中的 9 个中检测到。Nedd4L 的下调显著降低了体外培养的 G361 黑色素瘤细胞的生长。此外,外源性 Nedd4L 表达在异种移植试验中显著促进了 A2058 黑色素瘤细胞在体内的生长。这些发现表明,Nedd4L 的表达可能增加,以促进许多黑色素瘤中的肿瘤生长。